Market Overview

Global Petri Dish Market to Surpass US$ 180 Million by 2026 – Coherent Market Insights

Share:

SEATTLE, July 23, 2018 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global petri dish market is estimated to be valued at US$ 155.2 million in 2017, and is projected to exhibit a CAGR of 3.6% over the forecast period (2018 – 2026).

Key Trends and Analysis of the petri dish market: Increased prevalence of infectious disease such as urinary tract infection, Tuberculosis , Ebola, Sexually Transmitted Disease, hospital acquired superbugs and respiratory infection associated disease worldwide are expected to drive petri dish market growth. According to study published in International Journal of Microbiology and Applied Science in 2018, around 150 Million people are diagnosed with UTI infection annually. Healthcare-acquired methicillin-resistant Staphylococcus aureus, which is kind of superbug is one of major infection that needs culture-based diagnosis. Petri dish market would be supported in this scenario.

Increased research and development efforts to find cure for chronic disease such as cancer, cardiovascular disease would be another major impetus for petri dish market. According to report by the International Federation of Pharmaceutical Manufacturer and Association published in 2017, pharmaceutical industry invests US$ 149.8 billion on research and development annually. There are more than 7,000 compounds in preclinical stage of development as per same source. Development in proteomics, genomics and personalized medicines (cell based, anti-body based drugs) would further support market for petri dish. Furthermore, according to 2012, EU Industrial R&D Investment Scoreboard, the pharmaceutical and biotechnology sectors represented 17.7% of business R&D expenditure in the world. Petri dish market is an essential part of any research efforts, which is expected to witness major traction due to increasing research activities by commercial companies and research institutes.

Well established healthcare infrastructure coupled with high adoption rate of new technology for the treatment of cancer in the developed region is expected to boost overall sales of petri dish in regions such as North America and Europe. There are over 200 companies engaged in development of personalized cell therapy products in the U.S. alone.

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/petri-dish-market-1978

Key Market Takeaways:

  • The petri dish market is expected to exhibit a CAGR of 3.6% during the forecast period (2018– 2026), attributed to high prevalence of the infectious disease worldwide and large reliance on culture based diagnostic tests that requires petri dish.
  • Market growth is attributed to increasing efforts in research and development activities in commercial and academic spaces to find cure for chronic disease and novel products such as 3D petri dish, disposable ecofriendly petri dish etc. launched by the key players would create new space for petri dish in largely stagnant market
  • Some of the major players operating in the global petri dish market include Aicor Medical, NEST Biotechnology, Thermo Fisher Scientific, Greiner Bio-One, Corning, Phoenix Biomedical, Millipore Sigma, Reinnervate, Narang Medical Limited, Biosigma S.r.l., Pall Corporation

Click here to Buy this Market Intelligence Report Now

Click the link below to have a look at the sample before buying

Request Sample Pages of this Report

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave. 
#3200 
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

Primary Logo

View Comments and Join the Discussion!